Article
US FDA approves Pfizer's next-generation pneumococcal vaccine
Rating:
0.0
Views:
61
Likes:
1
Library:
1
The U.S. Food and Drug Administration (FDA) has approved Pfizer Inc's next-generation vaccine to prevent pneumococcal disease in children aged six weeks to 17 years, the company said late on Thursday.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value